Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
AI-Driven and Automated Continuous Oxygen Saturation Monitoring and LTOT: A Systematic Review
ABSTRACT
Long-term oxygen therapy (LTOT) is a foundational intervention for individuals with chronic hypoxemia, particularly those with chronic obstructive pulmonary disease (COPD). Traditional LTOT delivery relies on static oxygen flow prescriptions, often determined during clinical assessments, which may not reflect patients' fluctuating physiological demands during everyday activities. Recent innovations in computational modeling and automated systems have introduced tools capable of continuously monitoring peripheral oxygen saturation (SpO₂) and adjusting oxygen delivery in real time. This systematic review evaluates technologies designed to optimize SpO₂ monitoring and oxygen titration in LTOT. A comprehensive literature search was conducted across five databases (PubMed, Scopus, Web of Science, MDPI, and ACM Digital Library) for peer-reviewed studies published between 2000 and 2024. Studies were included if they described automated or computational systems applied to adult LTOT populations. Data were extracted on algorithm performance, motion artifact handling, usability, validation strategies, and risk of bias. Eight studies met the eligibility criteria, including five that utilized AI-based SpO₂ estimation methods and three that implemented closed-loop oxygen control systems. AI models demonstrated strong technical accuracy (mean absolute error as low as 0.57%) and addressed key limitations such as motion artifacts and signal bias. However, most were tested under simulated or retrospective conditions. Rule-based systems such as O₂matic and iPOC showed promising results in clinical and ambulatory settings but lacked personalized adaptation. Findings suggest that AI and automation offer complementary benefits in advancing LTOT. Further work is needed to support real-world deployment, ensure equitable design, and align these innovations with regulatory and clinical practice standards.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.